TNSN98202A1 - Procede nouveau - Google Patents

Procede nouveau

Info

Publication number
TNSN98202A1
TNSN98202A1 TNTNSN98202A TNSN98202A TNSN98202A1 TN SN98202 A1 TNSN98202 A1 TN SN98202A1 TN TNSN98202 A TNTNSN98202 A TN TNSN98202A TN SN98202 A TNSN98202 A TN SN98202A TN SN98202 A1 TNSN98202 A1 TN SN98202A1
Authority
TN
Tunisia
Prior art keywords
methoxy
new process
present
benzimidazole
dimethyl
Prior art date
Application number
TNTNSN98202A
Other languages
English (en)
French (fr)
Inventor
Hanna Cotton
Magnus Larsson
Anders Mattson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN98202A1 publication Critical patent/TNSN98202A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
TNTNSN98202A 1997-11-14 1998-11-09 Procede nouveau TNSN98202A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704183A SE9704183D0 (sv) 1997-11-14 1997-11-14 New process

Publications (1)

Publication Number Publication Date
TNSN98202A1 true TNSN98202A1 (fr) 2005-03-15

Family

ID=20408989

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98202A TNSN98202A1 (fr) 1997-11-14 1998-11-09 Procede nouveau

Country Status (35)

Country Link
US (1) US6303788B1 (enExample)
EP (1) EP0964859A1 (enExample)
JP (1) JP2001508466A (enExample)
KR (1) KR20000070069A (enExample)
CN (1) CN1145624C (enExample)
AR (1) AR013740A1 (enExample)
AU (1) AU750743B2 (enExample)
BR (1) BR9806871A (enExample)
CA (1) CA2276753A1 (enExample)
DE (1) DE964859T1 (enExample)
DZ (1) DZ2641A1 (enExample)
EE (1) EE04154B1 (enExample)
ES (1) ES2138950T1 (enExample)
GR (1) GR990300046T1 (enExample)
HR (1) HRP990218A2 (enExample)
HU (1) HUP0003737A3 (enExample)
ID (1) ID21999A (enExample)
IL (1) IL130647A0 (enExample)
IN (1) IN190801B (enExample)
IS (1) IS5106A (enExample)
MA (1) MA26564A1 (enExample)
MY (1) MY118199A (enExample)
NO (1) NO318197B1 (enExample)
NZ (1) NZ336447A (enExample)
PL (1) PL334701A1 (enExample)
RU (1) RU2211218C2 (enExample)
SE (1) SE9704183D0 (enExample)
SK (1) SK87299A3 (enExample)
TN (1) TNSN98202A1 (enExample)
TR (1) TR199901643T1 (enExample)
TW (1) TW588046B (enExample)
UA (1) UA68342C2 (enExample)
WO (1) WO1999025711A1 (enExample)
YU (1) YU31199A (enExample)
ZA (1) ZA989999B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
CZ20032351A3 (cs) 2001-02-02 2004-08-18 Tevaápharmaceuticaláindustriesáltd Způsob výroby substituovaných @@}@@pyridylmethylB sulfinyl @�H@benzimidazolů
SE0203092D0 (en) 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006040635A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited Processes for the preparation of substituted sulfoxides
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
CN1810803B (zh) * 2006-02-17 2010-11-17 中国科学院上海有机化学研究所 高对映体选择性制备(s)-奥美拉唑的方法
CN101538264A (zh) * 2008-03-19 2009-09-23 中国科学院成都有机化学有限公司 手性亚砜类化合物的制备新方法
CN102603621B (zh) * 2012-02-07 2013-09-04 成都苑东药业有限公司 一种新型手性亚砜化合物和以该化合物制备埃索美拉唑钠的方法
CN106083819A (zh) * 2016-06-08 2016-11-09 扬子江药业集团有限公司 一种奥美拉唑的制备方法
ES2948511A1 (es) * 2021-09-08 2023-09-13 Fundacion Para La Investigacion Biomedica Del Hospital Univ De La Princesa Derivados de n-sulfonilureas y su uso terapeutico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
SE9002043D0 (sv) 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider

Also Published As

Publication number Publication date
DE964859T1 (de) 2000-05-04
JP2001508466A (ja) 2001-06-26
HRP990218A2 (en) 2000-08-31
MA26564A1 (fr) 2004-12-20
ZA989999B (en) 1999-06-17
IL130647A0 (en) 2000-06-01
AU1058299A (en) 1999-06-07
PL334701A1 (en) 2000-03-13
HUP0003737A3 (en) 2002-01-28
CA2276753A1 (en) 1999-05-27
NO993298D0 (no) 1999-07-02
EP0964859A1 (en) 1999-12-22
GR990300046T1 (en) 2000-07-31
US6303788B1 (en) 2001-10-16
KR20000070069A (ko) 2000-11-25
NZ336447A (en) 2001-02-23
NO993298L (no) 1999-07-02
AR013740A1 (es) 2001-01-10
MY118199A (en) 2004-09-30
SE9704183D0 (sv) 1997-11-14
YU31199A (sh) 2002-06-19
CN1243512A (zh) 2000-02-02
ES2138950T1 (es) 2000-02-01
BR9806871A (pt) 2000-04-18
EE04154B1 (et) 2003-10-15
SK87299A3 (en) 2000-02-14
HUP0003737A2 (hu) 2001-10-28
IS5106A (is) 1999-07-02
TW588046B (en) 2004-05-21
ID21999A (id) 1999-08-19
RU2211218C2 (ru) 2003-08-27
NO318197B1 (no) 2005-02-14
TR199901643T1 (xx) 2000-01-21
CN1145624C (zh) 2004-04-14
EE9900391A (et) 2000-04-17
AU750743B2 (en) 2002-07-25
DZ2641A1 (fr) 2003-03-15
WO1999025711A1 (en) 1999-05-27
UA68342C2 (en) 2004-08-16
IN190801B (enExample) 2003-08-23

Similar Documents

Publication Publication Date Title
MY120745A (en) Novel form of s-omeprazole
TNSN00104A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
WO1999010320A8 (en) Substituted benzene compounds as antiproliferative and cholesterol lowering agents
ATE429416T1 (de) Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen
TR200200008T2 (tr) Fenofibratı ihtiva eden farmasötik bileşim ve bu bileşimin hazırlanması için yöntem
MA27316A1 (fr) Derives d'indoline-phenylsulfonamide
CA2174033A1 (fr) Nouveaux composes pyridiniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
TNSN00228A1 (fr) Derives de benzimidazole nouveaux, et compositions les contenant
YU31199A (sh) Novi postupak
TNSN00235A1 (fr) Derives d'heterocyclo-alkylsulfonylpyrazole nouveaux, procede pour leur preparation et compositions les contenant
TNSN00250A1 (fr) Composes nouveaux inhibiteurs de pcp, procede pour leur preparation et compositions les contenant
MA26725A1 (fr) Derives de resorcinol, compositions pharmaceutiques les contenant et procede pour leur preparation
RU99117541A (ru) Новый способ
CA2265538A1 (en) Method of omeprazole preparation
TNSN00105A1 (fr) Derives de 1-trifluoromethyl-4-hydroxy-7-piperidinyl- aminomethylchromane, procede pour leur preparation et compositions pharmaceutiques les contenant
WO2002092565A3 (en) 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
Simeone et al. Modification of the pyridine moiety of non-peptidyl indole GnRH receptor antagonists
TNSN00095A1 (fr) Benzolactames et thioamides cycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2869610A1 (fr) Derives de l'acide pentenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et leurs applications therapeutiques
RU95101840A (ru) Сложные эфиры циклогексанола и содержащий их фармацевтический препарат
BE1002181A3 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances.
BRPI0507407A (pt) sìntese assimétrica catalìtica de compostos de alfa-carbonila oticamente ativos
SE9902742D0 (sv) New pharmaceutical formultion
TH58464A (th) กรรมวิธีใหม่